Shannon McCue

Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome

Gülen Hatemi, Alfred Mahr, Yoshiaki Ishigatsubo et al. · New England Journal of Medicine · 2019 · 188 citations · Full text

Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial

Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno et al. · Clinical and Experimental Rheumatology · 2021 · 25 citations · Full text

A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis

Peter C. Taylor, Désirée van der Heijde, Robert Landewé et al. · The Journal of Rheumatology · 2021 · 14 citations

Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study

Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno et al. · RMD Open · 2022 · 13 citations · Full text